These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 13999593)

  • 1. Hepatic function in acne vulgaris patients treated with triacetyloleandomycin: A preliminary report.
    WEINER AL; COHEN W
    J New Drugs; 1962; 2():307-9. PubMed ID: 13999593
    [No Abstract]   [Full Text] [Related]  

  • 2. LIVER FUNCTION STUDIES IN LONG-TERM TRIACETYLOLEANDOMYCIN THERAPY.
    ENGEL MF
    South Med J; 1963 Nov; 56():1279-81. PubMed ID: 14078379
    [No Abstract]   [Full Text] [Related]  

  • 3. Acne vulgaris treated with triacetyloleandomycin.
    PARKER W
    Med Times; 1962 Mar; 90():310-2. PubMed ID: 14483935
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of triacetyloleandomycin in treatment of infected acne.
    EDELSTEIN AJ
    Pa Med J; 1962 Feb; 65():188-90. PubMed ID: 13889160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Triacetyloleandomycin in the treatment of acne].
    SMITH H
    Union Med Can; 1963 Mar; 92():332-4. PubMed ID: 13989430
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of triacetyloleandomycin in the treatment of pustular and cystic acne: a double blind study.
    MORGINSON WJ; ESKELSON YD
    Antibiot Annu; 1959-1960; 7():657-9. PubMed ID: 14424141
    [No Abstract]   [Full Text] [Related]  

  • 7. Triacetyloleandomycin: further observations on the treatment of acne and pyodermas.
    OLANSKY S; MCCORMICK GE
    Antibiot Annu; 1959-1960; 7():652-6. PubMed ID: 14428587
    [No Abstract]   [Full Text] [Related]  

  • 8. Triacetyloleandomycin (TAO)-its value in acne and certain pyogenic skin eruptions. J.
    LOVEMAN AB; HAMMOND K
    J Ky Med Assoc; 1959 Dec; 57():1507-10. PubMed ID: 13853712
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial of triacetyloleandomycin in the treatment of acne conglobata, nummular dermatitis and other resistant coccogenous dermatologic infections.
    KLESSENS NF
    Antibiot Chemother (Northfield); 1962 Aug; 12():551-3. PubMed ID: 14456900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies of the hepatotoxicity of triacetyloleandomycin (TAO) in humans].
    Sasso C; Arpino E
    Minerva Med; 1969 May; 60(35):1689-94. PubMed ID: 5306225
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergic reactions to oral antibacterials in hypersensitive patients. Toxicity studies on triacetylolzandomycin. II.
    GRATER WC
    Ann Allergy; 1962 Sep; 20():593-6. PubMed ID: 13949915
    [No Abstract]   [Full Text] [Related]  

  • 12. HEPATIC DYSFUNCTION AND FIXED-DRUG ERUPTION DUE TO TRIACETYLOLEANDOMYCIN.
    MONTES LF; MIDDLETON JW; FISHER A
    Lancet; 1964 Mar; 1(7334):662-3. PubMed ID: 14107946
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM
    Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prolonged cures with triacetyloleandomycin (T.A.O.) in the treatment of acne].
    GRUPPER C
    Sem Hop; 1961 Jul 4-10; 37():2205-7. PubMed ID: 13709277
    [No Abstract]   [Full Text] [Related]  

  • 15. Triacetyloleandomycin: its use in the treatment of acne and pyodermas caused by resistant Staphylococcus aureus.
    OLANSKY S; McCORMICK GE
    Antibiot Annu; 1958-1959; 6():265-7. PubMed ID: 13637746
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic dysfunction associated with triacetyloleandomycin demonstrated by "challenge".
    ROBINSON MM
    Am J Med Sci; 1962 Aug; 244():221-4. PubMed ID: 14492927
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on triacetyloleandomycin in the prevention of rheumatic fever: its effects on hepatic function].
    Gilbert G; Tardif B; Lefebvre M; David P
    Laval Med; 1967 Dec; 38(10):911-4. PubMed ID: 5302265
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 19. [On a case of tibial staphylococcal osteomyelitis treated with triacetyloleandomycin].
    NOVELLO AC; VALOTTA OJ
    Prensa Med Argent; 1962 Aug; 49():1824-6. PubMed ID: 13939116
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.